MedPath

Association Between Smell Training and Quality of Life in Patients With Impaired Sense of Smell Following COVID-19

Not Applicable
Recruiting
Conditions
COVID-19
Interventions
Other: Olfactory training with essential oils
Other: Olfactory training with fragrance-free oils
Registration Number
NCT05539560
Lead Sponsor
Ditte Gertz Mogensen
Brief Summary

Aim: The aim is to investigate whether guided systematic olfactory training with essential oils to improve impaired sense of smell following COVID-19, can improve patients' quality of life.

Hypothesis: The impaired quality of life in patients with impaired sense of smell following COVID-19, can be significantly improved in patients performing olfactory training with essential oils, compared to patients performing olfactory training with placebo oils.

Study design: The study is a randomized clinical trial with an intervention group and a control group. The intervention group receive four essential oils with scents of orange, lavender, clove, and peppermint. Patients in the control group receive a fragrance kit, consisting of the same containers, but with fragrance-free oils added. Both groups are instructed to smell each of the four oils for 30 seconds in the morning and evening, over a three-month intervention period. Patients are given a diary in which to record their olfactory training. The nurse or medical student instructing the patients in the training and performing the smell and taste tests is blinded.

Study population: Patients referred to the Unit for Sense of Taste and Smell in the Department of Otorhinolaryngology Head \& Neck and Audiology at Rigshospitalet.

Inclusion criteria:

* Impaired sense of taste and smell following COVID-19 \> 3 months

* Hyposmia (15-30) or anosmia (\<15) assessed by Sniffin' Sticks Olfactory Test for Threshold, Discrimination and Identification (TDI) performed in the Unit for Sense of Taste and Smell or medical assessment of parosmia based on medical history

* \> 18 years of age

Exclusion criteria:

* Cause of hyposmia, anosmia or parosmia other than COVID-19

* Impaired sense of taste and smell \>24 months

* Does not read or speak Danish

* Lack of compliance to perform daily olfactory training

Procedures:

* TDI-test: To assess patients' sense of smell, the TDI-test with Sniffin' Sticks is used, which is a validated tool with normative data.

* Taste test: To assess patients' sense of taste, taste sprays with the basic tastes are used.

Questionnaires:

* 'Taste and Smell Tool for Evaluation' is used to investigate quality of life related to impaired sense of taste and smell.

* 'Major Depression Inventory' (MDI) is used in the project to assess whether the patient is depressed and to make a possible assessment of the severity of depression.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Olfactory dysfunction caused by COVID-1
  • Hyposmia (15-30) or anosmia (<15) assessed by TDI test with Sniffin Sticks performed in the Unit for Sense of Taste and Smell or medical assessment of parosmia based on medical history
  • > 18 years of age
Exclusion Criteria
  • Cause of hyposmia, anosmia or parosmia other than COVID-19
  • Does not read or speak Danish
  • Lack of compliance to perform daily olfactory training

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupOlfactory training with essential oilsOlfactory training twice a day with essential oils
Control groupOlfactory training with fragrance-free oilsOlfactory training twice a day with fragrance-free oils
Primary Outcome Measures
NameTimeMethod
Change in Extended Sniffin' Sticks Test score3 months follow-up

Change in TDI score measured by Burghart Extended Sniffin' Sticks Test (TDI test). The TDI test, consists of a threshold test, a discrimination test, and an identification test. The results of the three subtests makes a total TDI score, where the minimum score is 1 and the maximum score is 48. A score \>30 indicates normal olfactory function, a score between 15-30 indicates hyposmia and a score \<15 indicates anosmia in the form of severely impaired or complete loss of olfaction.

Secondary Outcome Measures
NameTimeMethod
Change in Quality of Life3 months follow-up

Change in Quality of Life measured by the questionnaire Taste and Smell Tool for Evaluation. The minimum score is 21 and the maximum score is 105. A higher score means worse outcome (quality of life).

Trial Locations

Locations (1)

Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Copenhagen University Hospital

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath